Ladenburg Thalmann Financial Services’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,866
| Closed | -$54K | – | 5694 |
|
|
2019
Q3 | $54K | Sell |
2,866
-45
| -2% | -$848 | ﹤0.01% | 3404 |
|
|
2019
Q2 | $34K | Sell |
2,911
-6
| -0.2% | -$70 | ﹤0.01% | 3734 |
|
|
2019
Q1 | $40K | Hold |
2,917
| – | – | ﹤0.01% | 3565 |
|
|
2018
Q4 | $30K | Sell |
2,917
-104
| -3% | -$1.07K | ﹤0.01% | 3633 |
|
|
2018
Q3 | $50K | Sell |
3,021
-409
| -12% | -$6.77K | ﹤0.01% | 3318 |
|
|
2018
Q2 | $44K | Hold |
3,430
| – | – | ﹤0.01% | 3353 |
|
|
2018
Q1 | $44K | Sell |
3,430
-206
| -6% | -$2.64K | ﹤0.01% | 3353 |
|
|
2017
Q4 | $41K | Buy |
3,636
+858
| +31% | +$9.68K | ﹤0.01% | 3365 |
|
|
2017
Q3 | $33K | Buy |
2,778
+855
| +44% | +$10.2K | ﹤0.01% | 3385 |
|
|
2017
Q2 | $22K | Buy |
1,923
+1,700
| +762% | +$19.4K | ﹤0.01% | 3565 |
|
|
2017
Q1 | $4K | Sell |
223
-150
| -40% | -$2.69K | ﹤0.01% | 4429 |
|
|
2016
Q4 | $7K | Hold |
373
| – | – | ﹤0.01% | 4100 |
|
|
2016
Q3 | $12K | Hold |
373
| – | – | ﹤0.01% | 3733 |
|
|
2016
Q2 | $10K | Buy |
373
+150
| +67% | +$4.02K | ﹤0.01% | 3800 |
|
|
2016
Q1 | $6K | Sell |
223
-26
| -10% | -$700 | ﹤0.01% | 4022 |
|
|
2015
Q4 | $9K | Hold |
249
| – | – | ﹤0.01% | 3759 |
|
|
2015
Q3 | $9K | Sell |
249
-800
| -76% | -$28.9K | ﹤0.01% | 3626 |
|
|
2015
Q2 | $56K | Buy |
1,049
+49
| +5% | +$2.62K | ﹤0.01% | 2513 |
|
|
2015
Q1 | $29K | Sell |
1,000
-6,750
| -87% | -$196K | ﹤0.01% | 2955 |
|
|
2014
Q4 | $225K | Buy |
7,750
+6,900
| +812% | +$200K | 0.01% | 1344 |
|
|
2014
Q3 | $11K | Sell |
850
-5,750
| -87% | -$74.4K | ﹤0.01% | 3071 |
|
|
2014
Q2 | $132K | Buy |
+6,600
| New | +$132K | ﹤0.01% | 1431 |
|